Associated tags: Huntington Medical Research Institutes, Migraine, Brain, DSM-IV codes, HMRI, Heart, Medical imaging, Health, Research, Science, General Health, Other Science, Consumer, Biomedical Research, Student, Hydrocephalus, Women, Degenerative disease, Cardiology, Doctor of Philosophy, Medicine, Men, Other Health
Retrieved on:
Thursday, January 4, 2024
Research,
Seniors,
Men,
Cardiology,
Biotechnology,
Health,
Consumer,
Pharmaceutical,
Science,
Patient,
Exercise,
HMRI,
ED,
Risk,
Nitrate,
Woman,
PDE5,
Hypotension,
Moyamoya disease,
B cell,
Mortality,
Regenerative medicine,
Pharmacist,
Platelet-rich plasma,
MBA,
MD,
Doctor of Philosophy,
Huntington Medical Research Institutes,
Pulmonary hypertension,
Tadalafil,
University,
CVD,
Death,
CAC,
System,
CT scan,
Oxygen,
American College,
Contra,
Overalls,
Dietary supplement,
Princeton University,
Ischemia,
Journal,
Female,
Johns Hopkins,
Erectile dysfunction,
Pharmaceutical industry Their summary and guidelines have now been published in the Journal of Sexual Medicine.
Key Points:
- Their summary and guidelines have now been published in the Journal of Sexual Medicine.
- They determined that PDE-5 inhibitors are still safe for the cardiovascular system.
- The conference was funded by an unrestricted grant from Sanofi to readdress the cardiovascular workup of men presenting with ED and the cardiovascular safety of the phosphodiesterase-5 (PDE-5) inhibitors for treating ED.
- Patients with ED should be characterized as low-risk, intermediate (or indeterminable), or high-risk of developing a cardiac event with sexual activity.
Health,
Other Health,
Other Science,
General Health,
Research,
Science,
Biotechnology,
USC Marshall School of Business,
University,
PwC,
Education,
Liver disease,
Fatty liver disease,
Business,
Biomedical Research,
American Liver Foundation,
Private practice,
Liver cancer,
Organization,
Huntington Medical Research Institutes,
Business administration,
Patient,
Health care,
HMRI,
Cooper,
Master of Business Administration,
Management Huntington Medical Research Institutes (HMRI), a leading biomedical research organization in Southern California with a 70-year track record of impact, announced it added Dr. Edward Mena and accountant Rick Wentzel to its board of directors.
Key Points:
- Huntington Medical Research Institutes (HMRI), a leading biomedical research organization in Southern California with a 70-year track record of impact, announced it added Dr. Edward Mena and accountant Rick Wentzel to its board of directors.
- “We are thrilled to welcome Edward and Rick to our board of directors,” Dr. Julia Bradsher, president and CEO of HMRI, said.
- He previously worked at the HMRI Liver Center and later opened his own private practice and research facility focused on liver disease.
- Mena and Wentzel join the distinguished HMRI Board of Directors , led by Board Chair Dr. Susan E. Kane.
Health,
Philanthropy,
General Health,
Women,
Other Philanthropy,
Other Science,
Research,
Foundation,
Consumer,
Science,
Clinical Trials,
Epilepsy,
Psychiatry,
Tissue,
Heart,
City of Hope National Medical Center,
Male,
Mechanics,
Depression,
Life,
In vivo magnetic resonance spectroscopy,
Schizophrenia,
Culture,
Public,
Henry Purcell,
Workplace,
3D,
Anxiety,
SURF,
DSM-IV codes,
Injury,
Biomedical Research,
Woman,
Brain,
Mentorship,
History,
Huntington Medical Research Institutes,
MRI,
Hydrocephalus,
Student,
City,
NASA,
Engineering,
HMRI,
STEM,
Biology,
Faculty,
Environment,
Family,
Female,
Dr B C Roy Institute of Medical Sciences & Research,
Nursing,
Management,
Medical imaging Women are and have been at the forefront of our most groundbreaking research for decades.
Key Points:
- Women are and have been at the forefront of our most groundbreaking research for decades.
- Dr. Marylou Ingram, one of the most influential women scientists at HMRI, was a senior research scientist when she arrived in 1982.
- Through a bequest, Ingram endowed the Marylou Ingram Chair in Medical Science Research, ensuring future HMRI researchers would have the resources to be as groundbreaking as she was.
- Dr. Julia Bradsher is a successful scientist, strategic leader and the dynamic CEO of HMRI, directing the institute in its focused growth strategy.
Retrieved on:
Tuesday, January 17, 2023
Research,
Men,
Cardiology,
Health,
Consumer,
Pharmaceutical,
General Health,
Other Science,
Science,
University of California, San Francisco,
ED,
Cardiovascular disease,
Sildenafil,
HMRI,
University,
Record,
Tadalafil,
Death,
Angioplasty,
MD,
Huntington Medical Research Institutes,
MACE,
Medicare,
Manuscript,
Risk,
Diabetes,
Mortality,
Heart failure,
Vardenafil,
Unstable angina,
Degenerative disease,
PDE5,
Doctor of Philosophy,
Keck School of Medicine of USC,
Erectile dysfunction,
Pharmaceutical industry,
Sanofi,
Medicine This study marks a significant medical milestone, as it’s the first time the association between the use of PDE-5i drugs and cardiovascular health has been explored in a large population of relatively low-risk men with ED in the United States.
Key Points:
- This study marks a significant medical milestone, as it’s the first time the association between the use of PDE-5i drugs and cardiovascular health has been explored in a large population of relatively low-risk men with ED in the United States.
- In this study, scientists analyzed health records of more than 70,000 men with ED.
- The study, funded by a grant from Sanofi , examined records over approximately 14 years.
- The overall benefit in reduction of cardiac events was observed in men who also had risk factors for cardiovascular disease including diabetes.
Women,
Seniors,
Other Health,
Men,
Research,
Children,
Family,
Mental Health,
Medical Devices,
Consumer,
Science,
Cardiology,
General Health,
Biotechnology,
Neurology,
Health,
COVID-19,
Other Education,
Education,
Prostate cancer,
Student,
Learning,
Medicine,
Biomedical Research,
COVID-19,
Huntington Hospital,
Health,
Huntington Medical Research Institutes,
MBA,
Brain,
Heart,
Research,
Hydrocephalus,
Malaghan Institute of Medical Research,
Degenerative disease,
MRI,
HMRI,
Retractions in academic publishing,
Journal of Head Trauma Rehabilitation,
Patient,
Medical research,
Multimedia,
Migraine,
Hospital,
Science,
Doctor of Philosophy,
Microwave spectroscopy,
Medical device,
Management,
Medical imaging,
Kristin Pudenz Huntington Medical Research Institutes (HMRI), a leading biomedical research organization in Southern California, is celebrating its 70th anniversary by opening its doors to the public this Saturday, December 3, 2022, from 11 a.m. to 3 p.m. for its Holiday Open House.
Key Points:
- Huntington Medical Research Institutes (HMRI), a leading biomedical research organization in Southern California, is celebrating its 70th anniversary by opening its doors to the public this Saturday, December 3, 2022, from 11 a.m. to 3 p.m. for its Holiday Open House.
- We look forward to celebrating many more innovative discoveries in our focus areas of cardiovascular, neurovascular and neuroscience research.
- HMRI began as an outgrowth of two separate institutes: Pasadena Foundation for Medical Research, established in 1952, and the Institute of Medical Research of Huntington Memorial Hospital, founded in 1953.
- Huntington Medical Research Institutes (HMRI) is an independent, nonprofit organization located in Pasadena, California.
